Association of Smoking and Young Cryptogenic Ischemic Stroke
Dr. Dan Ackerman talks with Dr. Phillip Ferdinand about the association between smoking and young cryptogenic ischemic stroke. Read the related article in Neurology® Open Access. Disclosures can be fo...
20 Maalis 202515min
Revolutionizing ALS Treatment: The Tofersen Breakthrough
Dr. Gordon Smith talks with Dr. Timothy Miller about compelling patient stories and clinical data that highlight the potential for recovery in ALS patients, emphasizing the importance of early interve...
17 Maalis 202518min
Frontotemporal Dementia Differential Diagnosis in Clinical Practice
Dr. Trey Bateman talks with Dr. Amy Brodtmann about the complexities of diagnosing FTD and related disorders, emphasizing the need to understand frontal network impairments and the importance of behav...
13 Maalis 202527min
The Best of Headache Medicine from 2024: A Year in Review
Dr. Tesha Monteith talks with Dr. Patricia Pozo-Rosich about the latest advancements in headache medicine, focusing on key research findings from 2024.
10 Maalis 202516min
Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing MS
Dr. Alison Christy talks with Dr. Wallace J. Brownlee about whether dissemination in time (DIT) is necessary to make a diagnosis of MS in patients who fulfill a high number of dissemination in space (...
6 Maalis 202511min
Overview from the 2025 International Stroke Conference
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about the latest findings from the International Stroke Conference, focusing on advancements in stroke treatment and recovery. Read more about th...
3 Maalis 202519min
March 2025 Recall: Topics on Peripheral Neuropathy and Radiculopathy
The March 2025 replay features four previously released episodes focused on peripheral neuropathy and radiculopathy. The episode begins with Dr. Anne Oaklander discussing the association between long ...
1 Maalis 20251h 14min
Exploring GLP-1 Receptor Agonists for Neurodegeneration
Dr. Vikram Karnik talks with Dr. Lorraine V. Kalia about the potential role of GLP-1 receptor agonists in neurodegenerative diseases, the current state of research, preclinical evidence, and future di...
27 Helmi 202518min
